Buscar
10/11/2025
Health Status and Use of Healthcare Services of Undocumented Migrant Sex Workers in Catalonia: A Descriptive Study Using Administrative Registries.
Dalmau-Bueno, Albert, Albert-Ballestar, Sergi, Mansilla, Rosa, Garcia-Altes, Anna. Health Status and Use of Healthcare Services of Undocumented Migrant Sex Workers in Catalonia: A Descriptive Study Using Administrative Registries.. International Journal of Environmental Research and Public Health. 2025; 22(11)DOI:10.3390/ijerph22111696. PMID:. IF:(Q/D).
10/11/2025
Estimating the prevalence of chronic insomnia in patients with non-cancer chronic pain: Study protocol of a multicenter cross-sectional study
Moreno, Vicente, Martin-Pardo, Carme, Medel, Javier, Monerris, Mar, Ferrándiz, Marta, Lorente, Luís, Server, Anna, Serrano, Ancor, Carnaval, Thiago, Montes, Antonio, Videla, Sebastián. Estimating the prevalence of chronic insomnia in patients with non-cancer chronic pain: Study protocol of a multicenter cross-sectional study. Medicine: Case Reports And Study Protocols. 2025; 6(6)DOI:10.1097/MD9.0000000000000386. PMID:. IF:(Q/D).
09/11/2025
Study protocol for developing the evaluation instrument of guideline adherence to GRADE approach (GRADE-Check)
Jin, YH, Yan, SY, Yao, XM, Dahm, P, Alonso-Coello, P, Brignardello-Petersen, R, Keitz, S, Rylance, J, Cheung, M, Agoritsas, T, Kunkle, R, Murad, MH, Guyatt, G. Study protocol for developing the evaluation instrument of guideline adherence to GRADE approach (GRADE-Check). BMJ Open. 2025; 15(11)DOI:10.1136/bmjopen-2025-105534. PMID:41213689. IF:2.300(Q2/3D).
08/11/2025
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
De Santis, M, Redorta, JP, Nishiyama, H, Krawczynski, M, Seyitkuliev, A, Novikov, A, Guerrero-Ramos, F, Zukov, R, Kato, M, Kawahara, T, Goeman, L, Puente, J, Hellmis, E, Powles, T, Radziszewski, P, Gust, KM, Vasey, P, Bigot, P, Fradet, Y, Hunting, J, Armstrong, J, Boulos, S, Hois, S, Shore, ND. Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial. LANCET. 2025; 406(10516)DOI:10.1016/S0140-6736(25)01897-5. PMID:41115436. IF:88.500(Q1/1D).